Disease × agent pairs

Myelodysplastic Syndromes (MDS): candidate agents with evidence

10 agents linked to Myelodysplastic Syndrome by at least one registered trial or two publications, ranked by the OSMF evidence score. Not treatment advice.

Research Tracker › Pairs › Myelodysplastic Syndromes (MDS)
Open Myelodysplastic Syndromes (MDS) in the Repurposing ExplorerMyelodysplastic Syndromes (MDS) hub

Cytarabine

Drug · tier A · 8 trials (0 recruiting) · 11 publications · score 73.0

Azacitidine

Drug · tier A · 8 trials (0 recruiting) · 13 publications · score 67.5

Cedazuridine

Drug · tier A · 8 trials (3 recruiting) · 4 publications · score 53.5

Hydroxyurea

Drug · tier A · 8 trials (1 recruiting) · 5 publications · score 53.5

Sirolimus

Drug · tier A · 8 trials (0 recruiting) · 2 publications · score 52.0

Daunorubicin Hydrochloride

Drug · tier A · 8 trials (1 recruiting) · 0 publications · score 49.0

Daunorubicin Liposomal

Drug · tier A · 8 trials (1 recruiting) · 0 publications · score 49.0

Tacrolimus Anhydrous

Drug · tier A · 8 trials (1 recruiting) · 0 publications · score 43.5

Doxorubicin Hydrochloride

Drug · tier A · 8 trials (0 recruiting) · 0 publications · score 37.5

Bexarotene

Drug · tier A · 1 trials (0 recruiting) · 0 publications · score 23.5

Research map, not treatment advice. Built 2026-10-07.